Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  retinoid analogue NRX 195183
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
IRX5183 in Treating Patients with Relapsed or Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: J15219, NCI-2017-00282, CRMS-62978, IRB00083855, NCT02749708
Start Over